<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Ekologiya cheloveka (Human Ecology)</journal-id><journal-title-group><journal-title xml:lang="en">Ekologiya cheloveka (Human Ecology)</journal-title><trans-title-group xml:lang="ru"><trans-title>Экология человека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1728-0869</issn><issn publication-format="electronic">2949-1444</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">702132</article-id><article-id pub-id-type="doi">10.17816/humeco702132</article-id><article-id pub-id-type="edn">TTHNVC</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL STUDY ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Prostate diseases in the context of uranium legacy in Kyrgyzstan</article-title><trans-title-group xml:lang="ru"><trans-title>Заболевания предстательной железы в условиях уранового наследия Кыргызстана</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>吉尔吉斯斯坦铀矿遗产地区的前列腺疾病</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-5317-2988</contrib-id><name-alternatives><name xml:lang="en"><surname>Toktoraliev</surname><given-names>Zamirbek B.</given-names></name><name xml:lang="ru"><surname>Токторалиев</surname><given-names>Замирбек Биймырзаевич</given-names></name><name xml:lang="zh"><surname>Toktoraliev</surname><given-names>Zamirbek B.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><email>toktoralievzamirbek81@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-6103-7711</contrib-id><contrib-id contrib-id-type="spin">6882-9545</contrib-id><name-alternatives><name xml:lang="en"><surname>Matazov</surname><given-names>Bakyt A.</given-names></name><name xml:lang="ru"><surname>Матазов</surname><given-names>Бакыт Абдылдаевич</given-names></name><name xml:lang="zh"><surname>Matazov</surname><given-names>Bakyt A.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>toktoralievzamirbek81@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-6949-9147</contrib-id><contrib-id contrib-id-type="spin">8544-8707</contrib-id><name-alternatives><name xml:lang="en"><surname>Aliev</surname><given-names>Ramil R.</given-names></name><name xml:lang="ru"><surname>Алиев</surname><given-names>Рамиль Равиевич</given-names></name><name xml:lang="zh"><surname>Aliev</surname><given-names>Ramil R.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук </p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>ramil190517@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-8645-9072</contrib-id><contrib-id contrib-id-type="spin">2388-4558</contrib-id><name-alternatives><name xml:lang="en"><surname>Alimov</surname><given-names>Chynybek B.</given-names></name><name xml:lang="ru"><surname>Алимов</surname><given-names>Чыныбек Байышевич</given-names></name><name xml:lang="zh"><surname>Alimov</surname><given-names>Chynybek B.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>dr.chynybek.alimov@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4922-4673</contrib-id><contrib-id contrib-id-type="spin">7653-7900</contrib-id><name-alternatives><name xml:lang="en"><surname>Aldashukurov</surname><given-names>Yrysbek A.</given-names></name><name xml:lang="ru"><surname>Алдашукуров</surname><given-names>Ырысбек Абдыжапарович</given-names></name><name xml:lang="zh"><surname>Aldashukurov</surname><given-names>Yrysbek A.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>aldashukurov17@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8982-1993</contrib-id><contrib-id contrib-id-type="spin">7481-7230</contrib-id><name-alternatives><name xml:lang="en"><surname>Mamaev</surname><given-names>Tugolbay M.</given-names></name><name xml:lang="ru"><surname>Мамаев</surname><given-names>Туголбай Мамаевич</given-names></name><name xml:lang="zh"><surname>Mamaev</surname><given-names>Tugolbay M.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>д-р мед. наук </p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Medicine)</p></bio><email>tmamaev@oshsu.kg</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Osh State University</institution></aff><aff><institution xml:lang="ru">Ошский государственный университет</institution></aff><aff><institution xml:lang="zh">Osh State University</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Kyrgyz-Russian Slavic University n.a. B.N. Yeltsin</institution></aff><aff><institution xml:lang="ru">Кыргызско-российский славянский университет им. Б.Н. Ельцина</institution></aff><aff><institution xml:lang="zh">Kyrgyz-Russian Slavic University n.a. B.N. Yeltsin</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-05-18" publication-format="electronic"><day>18</day><month>05</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-08-21" publication-format="electronic"><day>21</day><month>08</month><year>2026</year></pub-date><volume>33</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>301</fpage><lpage>311</lpage><history><date date-type="received" iso-8601-date="2026-02-03"><day>03</day><month>02</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-04-07"><day>07</day><month>04</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><copyright-holder xml:lang="zh">Eco-Vector</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hum-ecol.ru/1728-0869/article/view/702132">https://hum-ecol.ru/1728-0869/article/view/702132</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold> This study is motivated by the potential impact of radiation associated with Kyrgyzstan's uranium legacy on the increasing prevalence of prostate disease among men. Ionizing radiation is a recognized risk factor for urological cancers and other diseases; however, no comprehensive studies of this relationship have been conducted in the region. This publication aims to review existing data, identify knowledge gaps, and make a case for targeted epidemiological and clinical research to protect public health.</p> <p><bold>AIM:</bold><bold><italic> </italic></bold>To identify the epidemiological characteristics and risk factors for prostate disease in men living in technogenically contaminated (uranium) areas of Kyrgyzstan.</p> <p><bold>METHODS:</bold><bold> </bold>The study was conducted in 2018–2024 in three areas of Kyrgyzstan with different levels of environmental contamination. It included 400 men aged 25–70 years who had lived in these areas for at least 10 years: 300 from Mailuu-Suu, 100 from Kadzhi-Say, and 100 from the Alai district (controls). Exposure was analyzed at both the group level (by place of residence) and the individual level. In 30% of participants from each group, urinary cadmium and lead levels were measured by inductively coupled plasma mass spectrometry. Individual exposure data were compared with environmental contamination data for the corresponding areas.</p> <p><bold>RESULTS:</bold><bold><italic> </italic></bold>Cadmium and lead concentrations in water and soil exceeded safety standards by 2.5–5.0 times. Strong positive correlations were found between cadmium in water and prostate disease (<italic>r</italic><italic> </italic>= 0.78; <italic>p</italic> &lt; 0.01), lead in soil (<italic>r</italic> = 0.73; <italic>p</italic> &lt; 0.05), and total radionuclide activity (<italic>r</italic> = 0.69; <italic>p</italic> &lt; 0.05).</p> <p><bold>CONCLUSION:</bold> Residence in uranium legacy zones is associated with an increased risk of prostate disease. The combined effect of heavy metals, radionuclides, and behavioral factors explains up to 64% of the variation in disease incidence. These findings support integrating environmental monitoring with medical surveillance to prevent urological diseases in technogenically contaminated regions.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Актуальность исследования обусловлена потенциальным влиянием радиационного фона, связанного с урановым наследием Кыргызстана, на рост заболеваемости патологиями предстательной железы среди мужского населения. Известно, что ионизирующее излучение выступает одним из признанных факторов риска развития онкологических и иных заболеваний мочеполовой системы, однако в регионе отсутствуют комплексные исследования, оценивающие эту взаимосвязь. Публикация призвана систематизировать имеющиеся данные, обозначить пробелы в знаниях и обосновать необходимость целенаправленных эпидемиологических и клинических исследований для защиты здоровья населения.</p> <p><bold>Цель.</bold> Выявить эпидемиологические особенности и факторы, влияющие на распространённость заболеваний предстательной железы среди мужчин, проживающих в техногенно загрязнённых (урановых) зонах Кыргызстана.</p> <p><bold>Методы.</bold> Исследование проведено в 2018–2024 гг. на трёх территориях Кыргызской Республики, различающихся по уровню техногенной нагрузки на окружающую среду. В исследование включены 400 мужчин 25–70 лет, проживающих на указанных территориях не менее 10 лет: 300 человек — из Майлуу-Суу, 100 человек — из Каджи-Сай, 100 человек — из Алайского района (контрольная группа). Техногенное воздействие проанализировано на групповом уровне по месту постоянного проживания, а также на индивидуальном уровне. У 30% участников из каждой исследуемой группы выполнено определение содержания кадмия и свинца в образцах мочи методом масс-спектрометрии с индуктивно связанной плазмой. Полученные индивидуальные показатели сопоставлены с результатами анализа загрязнения окружающей среды соответствующих территорий.</p> <p><bold>Результаты.</bold> Концентрации кадмия и свинца в воде и почве превышали санитарные нормативы в 2,5–5,0 раза. Установлена сильная прямая корреляция между содержанием кадмия в воде и заболеваниями предстательной железы (<italic>r</italic> = 0,78; <italic>p</italic> &lt; 0,01), свинца в почве (<italic>r</italic> = 0,73; <italic>p</italic> &lt; 0,05), а также суммарной активностью радионуклидов (<italic>r</italic> = 0,69; <italic>p</italic> &lt; 0,05).</p> <p><bold>Заключение.</bold> Проживание в зонах уранового наследия ассоциировано с повышенным риском заболеваний предстательной железы. Совокупное воздействие тяжёлых металлов, радионуклидов и поведенческих факторов объясняет до 64% вариаций заболеваемости. Результаты обосновывают необходимость интеграции экологического мониторинга и медицинского надзора для профилактики урологической патологии в техногенно загрязнённых регионах.</p></trans-abstract><trans-abstract xml:lang="zh"><p>论证。研究的现实意义源于吉尔吉斯斯坦铀矿遗产相关辐射本底对男性人群前列腺疾病发病率的潜在影响。已知电离辐射是泌尿系统肿瘤性疾病及其他疾病公认的风险因素之一，但该地区缺乏评估这种关联的综合研究。本文旨在系统化现有数据，指明知识空白，并论证为保护人口健康而开展针对性流行病学和临床研究的必要性。</p> <p>目的。揭示居住在吉尔吉斯斯坦人为污染（铀污染）区男性前列腺疾病的流行病学特征及影响其患病率的因素。</p> <p>方法。研究于2018–2024年在吉尔吉斯共和国三个环境人为负荷水平不同的地区进行。研究纳入400名25–70岁、在上述地区居住不少于10年的男性：300人来自迈卢-苏区，100人来自卡吉-赛区，100人来自阿赖地区（对照组）。人为影响在群体层面（按常住地）和个体层面进行了分析。每组30%的参与者采用电感耦合等离子体质谱法测定了尿样中的镉和铅含量。获得的个体指标与相应地区的环境污染分析结果进行了对比。</p> <p>结果。水和土壤中的镉、铅浓度超过卫生标准2.5–5.0倍。发现水中镉含量与前列腺疾病之间存在强正相关（r = 0.78; p &lt; 0.01），土壤中铅含量与前列腺疾病之间也存在强正相关（r = 0.73; p &lt; 0.05），总放射性核素活度亦是如此（r = 0.69; p &lt; 0.05）。</p> <p>结论。居住于铀矿遗产区与前列腺疾病风险升高相关。重金属、放射性核素和行为因素的复合影响可解释高达64%的发病率变异。结果证明有必要整合生态监测和医疗监督，以预防人为污染地区的泌尿系统疾病。</p></trans-abstract><kwd-group xml:lang="en"><kwd>prostate gland</kwd><kwd>uranium legacy</kwd><kwd>chronic prostatitis</kwd><kwd>benign prostatic hyperplasia</kwd><kwd>heavy metals</kwd><kwd>technogenic pollution</kwd><kwd>epidemiology</kwd><kwd>Kyrgyzstan</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>предстательная железа</kwd><kwd>урановое наследие</kwd><kwd>хронический простатит</kwd><kwd>доброкачественная гиперплазия</kwd><kwd>тяжёлые металлы</kwd><kwd>техногенное загрязнение</kwd><kwd>эпидемиология</kwd><kwd>Кыргызстан</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>前列腺</kwd><kwd>铀矿遗产</kwd><kwd>慢性前列腺炎</kwd><kwd>良性增生</kwd><kwd>重金属</kwd><kwd>人为污染</kwd><kwd>流行病学</kwd><kwd>吉尔吉斯斯坦</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Bicalho-Silva S, Ruiz TFR, Santos FCA, Taboga SR. Impacts of heavy metal exposure on the prostate of murine models: Mechanisms of toxicity. Toxicology Reports. Reproductive Toxicology. 2023;120(2014):108448. doi: 10.1016/j.reprotox.2023.108448</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Akhmadullina YuR, Krivoshchapova YaV. Dynamics of the frequency of unstable chromosome exchanges in lymphocytes of chronically exposed residents of the Ural region. Radiation Hygiene. 2025;18(3):36–45. doi: 10.21514/1998-426X-2025-18-3-36-45 EDN: JIVDZW</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Chen Ch, Xun P, Nishijo M, et al. Cadmium exposure and risk of prostate cancer: a meta-analysis of cohort and case-control studies among the general and occupational populations. Sci Rep. 2016;6:25814. doi: 10.1038/srep25814</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Pant N, Kumar G, Upadhyay AD, et al. Reproductive toxicity of lead, cadmium, and phthalate exposure in men. Environ Sci Pollut Res. 2014;21(18):11066–11074. doi: 10.1007/s11356-014-2986-5</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Bray F, Ferlay J, Laversanne M, et al. Global cancer statistics 2022: GLOBOCAN estimates. CA: A Cancer Journal for Clinicians. 2024;74(2):102–121.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Tilki D, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2024;86(2): 164–182. doi: 10.1016/j.eururo.2024.04.010</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>GBD 2019 Benign Prostatic Hyperplasia Collaborators. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2022;3(11):e754–e776. doi: 10.1016/S2666-7568(22)00213-6</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Zimta AA, Schitcu V, Gurzau E, et al. Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer development. Environ Res. 2019;178:108700. doi: 10.1016/j.envres.2019.108700</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ilieva I, Sainova I. Mechanisms of heavy metal toxicity in the male reproductive system. Open Acc Res Anatomy. 2022;2(5):000546. doi: 10.31031/OARA.2022.02.000546</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Vodovatov AV, Chipiga LA, Kosarlukova EA, et al. Medical diagnostic exposure in the Russian Federation: regulatory problems and proposals for their solution. Radiation Hygiene. 2025;18(3):46–61. doi: 10.21514/1998-426X-2025-18-3-46-61 EDN: NVAUIO</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ministry of Natural Resources, Ecology, and Technical Supervision of the Kyrgyz Republic. Joint convention on the safety of spent fuel management and on the safety of radioactive waste management. Bishkek; 2024. 30 p.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Salbu B. Preface: uranium mining legacy issue in Central Asia. J Environ Radioact. 2013;123:1–2. doi: 10.1016/j.jenvrad.2011.12.010</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Teregulov BF, Pavlov VN, Kudasheva AR, et al. Assessment of sexual health of male workers engaged in underground mining of polymetallic ores and living in a mining geochemical area. Occupational Health and Human Ecology. 2025;(1):49–63. doi: 10.24412/2411-3794-2025-10104 EDN: SNWODW4</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Korsakov AV, Golovleva AA, Troshin VP, et al. Ovarian malignancies frequency in the female population from the Bryansk region living in conditions of radioactive, chemical and combine contamination (2000–2020). Life. 2021;11(11):1272. doi: 10.3390/life11111272 EDN: CKNNZY</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Korsakov AV, Kryukova AE, Troshin VP, et al. Comparative assessment of the incidence of malignant neoplasms of the uterine cervix in women residing in areas with different levels of radiation, chemical and combined exposure. Hygiene and Sanitation . 2026;105(2):110–117. doi: 10.47470/0016-9900-2026-105-2-110-117 EDN: SINUNN</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Korsakov AV, Kryukova AE, Troshin VP, et al. Cervical and endometrial cancer incidence in the female population from the Bryansk region living in conditions of chemical, radioactive and combined environmental contamination (2000–2020). Life. 2022;12(10):1488. doi: 10.3390/life12101488 EDN: CBVHVY</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Vekilyan MA, Fomina AV, Gerasimova LI, Pak VI. Medical and social risk factors for prostate cancer (systematic review). Health Risk Analysis. 2026;(1):190–197. doi: 10.21668/health.risk/2026.1.18.eng</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Rodprasert W, Toppari J, Virtanen HE. Endocrine disrupting chemicals and reproductive health in boys and men. Front Endocrinol (Lausanne). 2021;12:706532. doi: 10.3389/fendo.2021.706532</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>United Nations Economic Commission for Europe (UNECE). Environmental performance review. Kyrgyzstan. 3rd ed. Geneva; 2024. 435 р.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Pizent A, Anđelković M, Tariba Lovaković B, et al. Environmental exposure to metals, parameters of oxidative stress in blood and prostate cancer: results from two cohorts. Antioxidants (Basel). 2022;11(10):2044. doi: 10.3390/antiox11102044</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Sayegh N, Gross K. Benign prostatic hyperplasia: a global challenge of the ageing population. The Lancet Healthy Longevity. 2022;3(11): e 725–e 726. doi: 10.1016/s2666-7568(22)00243-4 EDN: DKKKJZ</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Lim JT, Tan YQ, Valeri L, et al. Association between serum heavy metals and prostate cancer risk — а multiple metal analysis. Environ Int. 2019;132:105109. doi: 10.1016/j.envint.2019.105109</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Repin LV, Biblin AM. Development of a mobile application for assessing radiation risk associated with medical X-ray and radiological examinations. Radiation Hygiene. 2025;18(3):112–119. doi: 10.21514/1998-426X-2025-18-3-112-119 EDN: SBJSWV</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Lin X, Zhi Y. Global epidemiological trends in prostate cancer burden: a comprehensive analysis from Global Burden of Disease Study 2021. Transl Androl Urol. 2025;14(5):1238–1252. doi: 10.21037/tau-2025-103</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>World health statistics 2023: monitoring health for the SDGs, Sustainable Development Goals. Geneva: World Health Organization; 2023. 136 р. ISBN: 978-92-4-007432-3</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Shandala N K , Shitova A A , Isaev D V , et al. Assessment of the radiation state of the territory and coastal waters of the village of Amderma in the Nenets Autonomous Okrug. Radiation Hygiene. 2025;18(3):75–84. doi: 10.21514/1998-426X-2025-18-3-75-84 EDN: XJQJEK</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Coradduzza D, Sanna A, Di Lorenzo B, et al. Associations between plasma and urinary heavy metal concentrations and the risk of prostate cancer. Sci Rep. 2025;15(1):14274. doi: 10.1038/s41598-025-97682-0</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Holt JD, Garrett WA, McCurry TK, Teichman JM. Common questions about chronic prostatitis. Am Fam Physician. 2016;93(4):290–296 .</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>López-Botella A, Sánchez R, Paul R, Aizpurua J, Gómez-Torres MJ, Todolí-Torró JL. Analytical determination of heavy metals in human seminal plasma — a systematic review. Life. 2023;13(4):925. doi: 10.3390/life13040925</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Singh V, Madeshiya AK, Ansari NG, et al. CYP1A1 gene polymorphism and heavy metal analyses in benign prostatic hyperplasia and prostate cancer: An explorative case-control study. Urol Oncol. 2023;41(8):355.e9–355.e17. doi: 10.1016/j.urolonc.2023.04.022</mixed-citation></ref></ref-list></back></article>
